WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
After the success of BASL2019 Save the Date for BASL2020 - 8th - 11th September at The Guildhall in Plymouth. Next year's meeting will include joint symposiums with colleagues from AASLD.
BASL2019 ANNUAL MEETING
17th - 20TH September, University of STRATHCLYDE GLASGOW
BASL2019 Annual Meeting - Technology & Innovation Centre, University of Strathclyde, Glasgow. The BASL programme runs from Wednesday 18th September to lunchtime on Friday 20th, with the BLNA Nurses Day meeting running on Wednesday 18th PM & Thursday 19th. The BLTG programme runs from Tuesday 17th to lunchtime on Wednesday 18th September.
Visit the BASL Annual Meeting dedicated microsite for all the details; https://baslannualmeeting.org.uk/
BASL ANNUAL MEETING
BASL AND BASL SUB-GROUPS
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
British Liver Nurse Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.
The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group.
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research.
HCC UK is a multi-disciplinary organisation aiming to promote collaboration in research, education and clinical service development for primary liver cancer. We bring together leading oncologists, liver surgeons, hepatologists, basic scientists, radiologists, pathologists and specialist nurses to lead improvement in the quality of patient care.
More than a quarter of people who die from liver disease in hospital have no previous admission in the year before their deathRead more
Press Release - British Liver Trust
More than a quarter of people who die from liver disease in hospital have no previous admission in the year before their death
New data released today at the largest conference for liver clinicians reveals that around 5,200 people die from liver disease in hospital in England each year. Of these, 30% of those have not had an admission in the year before death. On admission to hospital time is of the essence in saving these seriously ill patients. 1 in 4 of those who die do not survive more than 3 days and 43% do not survive a week.
These are people with advanced liver disease and many of their lives could have been saved if they had been diagnosed earlier in primary or secondary care and had been given advice on risk factors like alcohol and management of their liver disease.
The analysis is being presented at the British Association for the Study of the Liver conference in Glasgow. The data also reveals that these deaths occur in relatively young people. 60% of these patients are under 64 years of age and that one in five are under the age of 50.
Liver disease has increased by 400% since 1970 and it’s the biggest cause of death in those aged between 35-49 years old in the UK (https://britishlivertrust.org.uk/about-us/media-centre/statistics/ ).
This new data highlights the urgent need for improvements in early detection of the disease as most patients are being diagnosed too late in an emergency setting.
Professor Matthew Cramp, president at BASL, says: “Many people with liver disease are unaware that they have it because there are usually have no symptoms in the early stages. Too often the first a patient knows about their liver disease is when they are admitted as an emergency to hospital with life threatening complications. Even with the doctors’ best efforts some patients are so ill that their life cannot be saved.”
“It’s vital that GPs and other healthcare professionals identify those at risk so that more patients are diagnosed at an early stage.”
The research used Office for National Statistics mortality data and Hospital Episode Statistics data supplied by NHS Digital. Other alarming facts highlighted by the research:
• 29.1% of the patients who died in hospital had no previous admission in the year
• 20.8% had only one previous admission in the year before they died
• 25.3% of those who die do not survive more than 3 days in hospital
• 43% of those who die do not survive more than a week in hospital.
• 2,230 liver patients die each year in hospital in a week or less from admission, that is 43 patients per week or 6 patients every day.
• The majority (60%) of those dying from liver disease in hospital are under the age of 64 and 20% are under the age of 50.
• At least two-thirds of the patients who died with no previous admission in the year before death died from alcohol related liver disease
• Patients admitted to hospitals with specialist liver services are more likely to be seen by a specialist in liver disease and be admitted to ITU
Professor Matthew Cramp, president at BASL, says: “Despite being young and very sick, many patients die from the disease without ever being seen or cared for by a specialist. Patients with life-threatening liver disease complications need to be recognised quickly when they arrive at hospital and should be seen by a specialist with knowledge of liver disease quickly and treated according to Guidelines.”
This study found that the chance of these patients being seen by a specialist (Gastroenterologist or hepatologist) and being admitted to ITU was higher if they were admitted to a hospital with specialist liver services.
Matthew Cramp adds: “Smaller hospitals should link with specialist hospitals to consult with experts or transfer patients if appropriate.”
Liver problems develop silently with no obvious symptoms in the early stages yet if caught early, the disease can be reversed through lifestyle changes. More than 90% of liver disease is due to three main risk factors: obesity, alcohol and viral hepatitis.
Pamela Healy, Chief Executive, British Liver Trust said, “This research highlights the liver disease epidemic we are facing in the UK. While the data presented is based on England only, this is likely to reflect the situation with liver disease in Scotland, Wales and Northern Ireland.”
To coincide with the BASL conference, The British Liver Trust’s Love Your Liver roadshow is at the University of Strathclyde today offering free liver health screening and scanning.
Pamela continues: “Helping people understand how to reduce their risk of liver damage is vital to address the increase in deaths from liver disease. Although the liver is remarkably resilient, if left too late damage is often irreversible. I would urge everyone who is unable to attend the roadshow to take our online screener on our website to see if they are at risk.”
1. For additional information of please refer to the following:
• The 2nd Atlas of variation in risk factors and healthcare for liver disease in England published by PHE and NHS Rightcare in 2017: https://fingertips.phe.org.uk/profile/atlas-of-variation
• There is an interactive version of the Atlas at http://tools.england.nhs.uk/images/LiverAtlas17/atlas.html
2. The Love Your Liver Campaign focuses on three simple steps to Love Your Liver back to health:
i) Drink within recommended limits and have three consecutive days off alcohol every week
ii) Cut down on sugar, carbohydrates and fat, and take more exercise
iii) Know the risk factors for viral hepatitis and get tested or vaccinated if at risk
3. The roadshow comprises a mobile unit where people can take a free online screening test and find out if they are at risk. Free liver health scanning is also offered using a non-invasive device. Expert guidance on how to keep your liver healthy from healthcare profession.
New study shows alcohol service saves NHS moneyRead more
Press Release - British Liver Trust
New study shows alcohol service saves NHS money
New evidence being presented today at the British Association for the Study of the Liver (BASL) conference in Glasgow shows that an innovative new service treating people who are alcohol dependent is having dramatic effects and saving the NHS money.
The liver unit from University Hospitals Plymouth NHS Trust has developed a new service that has turned traditional ways of treating people with alcohol dependency on its head. They analysed data over the first six months of the pilot service, and found that their new service had saved £78,400 in acute hospital bed days alone, not counting additional savings including ambulance and social services costs.
The Assertive Alcohol Outreach Service (AAOS) in Plymouth identifies frequent users of A&E who are alcohol dependent. They then provide targeted intensive bespoke care that is highly individualised for six months. By visiting their homes, liaising with family members, and other services such as social care, housing, and debt services they are achieving improved health outcomes for the individual patients as well as saving money.
People who frequently attend A&E departments for alcohol-related reasons place a disproportionate burden on hospital bed usage. Although A&E staff are generally sympathetic to the needs of people with complex drinking and related problems, they do not have the resources or training to provide the kind of personalised support that people who frequently attend A&E with alcohol-related problems often need. One in ten people in the hospital system in the UK are alcohol dependent.1
The Plymouth team set out to address these alarming statistics by trying a completely different approach.
Louise Dunn who leads the nurse led service said, “These patients have complex needs and often don’t interact with traditional service models. This service puts the patient at the centre, builds relationships and really considers what is needed for each particular individual.”
Users of the service reported how it had improved their family relationships, quality of life family dynamics, improved health, and enabled them to engage more effectively.
One user commented, “I've never got on with other services as they treat you like they have a recipe book and if you’re not on their ingredients list, they can't help you. But AAOS have thrown away the recipe book, looked at the ingredients, (me) and just cooked with what you've got and that's why I think it's finally worked!"”
Pam Healy, Chief Executive of the British Liver Trust said, “The NHS Long Term Plan has recommended hospital-based alcohol care teams as one of the key interventions for preventing illness and reducing health inequalities. This new evidence suggests that this may be an excellent model for how they could deliver their services to ensure that they are integrated and truly meet the needs of patients.”
1. A major review published in July 2019 pulled together the results of 124 previous studies involving 1.6 million hospital inpatients revealed that one in ten people in the hospital system are alcohol dependent. https://onlinelibrary.wiley.com/doi/10.1111/add.14642
Minimum unit pricing in Scotland has had biggest impact on drinking patterns in GlasgowRead more
Press Release - British Liver Trust
Minimum unit pricing in Scotland has had biggest impact on drinking patterns in Glasgow
Thursday 19th May 2019 - Evidence released today at the UK’s largest conference for liver experts shows that minimum unit pricing, introduced in Scotland in May 2018, may have had a significant impact amongst Scotland’s heaviest drinkers in Glasgow where there has been a reduction in alcohol-related deaths.
The research being presented at the British Association for the Study of the Liver (BASL) conference in Glasgow has important implications for MUP in England and the rest of the UK. The key findings are:
• Glasgow City has seen a 21.5% reduction in alcohol-related deaths from 2017 to 2018: 186 to 146.
• Almost half (44%) of the alcohol-related deaths in 2018 in Glasgow occurred before May 2018 when MUP was introduced.
Speaking at the BASL event, Dr Ewan Forrest, said when presenting the results:
“Glasgow has always had much higher levels of alcohol-related deaths than other parts of Scotland. This latest information suggests that MUP may be reducing alcohol-related harm in those at highest risk. More time is needed to assess the effect on MUP on the rest of Scotland and to get a clearer idea as to how MUP might affect the rest of the UK.”
Professor Matthew Cramp, President of BASL adds: “This early evidence suggests that implementing MUP does exactly what it is supposed to – it is a highly targeted measure that improves the health of the heaviest drinkers and those experiencing the most harm from alcohol whilst those who drink in moderation continue much as before.”
Scotland was the first country in the world to implement a minimum unit price for alcohol, following a ten-year campaign by health bodies including the British Liver Trust.
The Alcohol (Minimum Pricing) (Scotland) Act 2012 states that all alcohol sold through licensed premises in Scotland cannot be sold below a set minimum unit price (MUP). The MUP depends on the amount of alcohol contained in the product and is currently set at 50p per unit of alcohol.
Pamela Healy, Chief Executive of the British Liver Trust said, “We are facing a liver disease epidemic in the UK and a major reason for this is that as a nation we are drinking too much alcohol.
“There is good evidence that interventions such as minimum unit pricing (MUP), targeted taxes and marketing regulations reduce alcohol harm. Alcohol taxes have been cut repeatedly in real terms. The Government needs to look carefully at the outcomes from Scotland on MUP so that more lives can be saved.
The British Liver Trust is the largest UK charity for all adults with liver disease., which is the third leading cause of premature death. Their Love Your Liver roadshow is in Scotland this week raising awareness of the risk factors of the disease, including alcohol misuse.
The British Liver Trust urges everyone to take their online screening test to find out if they are at risk of liver disease: www.britishlivertrust.org.uk/screener .
Vacancy - Clinical Lecturer in Hepatology, Queen Mary & Barts HealthRead more
This is an exciting opportunity for a Clinical Lecturer to build upon their existing track record of clinical and academic excellence, to undertake post-doctoral research and to develop their own externally-funded research programme in Hepatology. The successful candidate will work with Dr William Alazawi within Barts Liver Centre and the Centre for Immunobiology. The group is particularly focused on non-alcoholic fatty liver disease, with recent high-impact epidemiological clinical translational and basic science publications in the field.
For further details, please visit https://www.jobs.nhs.uk/xi/vacancy/?vac_ref=915733563. Closing date for applications: 1 October 2019.
BASL Trainee Mentoring Sessions at BASL / BLTG 2019Read more
The mentoring sessions will be informal and will cover advice on career development. The sessions will be led by Professor Michael Heneghan, Consultant Hepatologist & Professor of Hepatology at the Institute of Liver Studies, King's College Hospital.
When - the morning of Wednesday 18th September 2019
Where – during the BASL / BLTG Annual Meeting at the Technology & Innovation Centre, University of Strathclyde, Glasgow
Criteria – you must be a BASL Medically Qualified in Training Member and be registered for the BASL / BLTG Annual Meeting 2019.
Times - a session can be booked in advance and 30-minute time slots are available between 10:00 – 13:00 and are being offered on a first come first served basis. The final sessions will start at 12:30.
To Book - register for a mentoring session in advance by emailing email@example.com before 2 p.m. on Friday 6th September 2019. Alternatively speak with colleagues on the day at the Registration Desk at BASL2019 to book a session.
We look forward to seeing you in Glasgow.
The Cambridge Annual Liver Symposium is taking place on Friday 27th September from 08:30 – 16:00.
Venue: Robinson College, Cambridge.
Dinner: Thursday 26th September 20:00.
- Autoimmune / PSC
- NASH/fibrosis assessment
- Genetic liver disorders
- Interactive MDT-style cases (viral/portal HT)
Download a copy of the programme here > Download Camliversymp2019finalprog.pdf
FREE to attend and CPD accredited (6 points).
If you have any questions and to reserve your place please contact firstname.lastname@example.org or telephone: 01223 586 891.
FRONTIERS IN HEPATOLOGY VIII – ALCOHOL & NON-ALCOHOLIC STEATOHEPATITIS
One day CPD accredited conference and the content would be of value to all those specialising in Hepatology and Gastroenterology including, Academics, NHS Consultants and SpR’s.
Date:Tuesday 8th October 2019
Venue: The Institute of Hepatology London, 111 Coldharbour Lane, London, SE5 9NT
This event brings together a number of ‘thought-leaders’ and experts to highlight the increasing prevalence of ASH/NASH and aims to provide an overview of the pathogenesis, epidemiology and therapeutic implications of this co-morbidity, with a particular focus on the overlapping causes and pathways.
A programme and application form can be downloaded from the Foundation for Liver Research website > http://www.liver-research.org.uk/newsletter/hepatology-conferences.html or below.
Download a copy of the programme here > Download Frontiers programme R1 19.pdf
An application form to register for the meeting can be downloaded here > Download Registration Form Frontiers in Hepatology.pdf
For more details, please contact Enda O’Sullivan on 020-7255 9833 or e-mail:email@example.com.
UK-PSC are organising a UK PSC Study Day that will be held on Friday 25th of October 2019 in Leeds (UK), at the Hilton Hotel. We are hoping that you would be able to attend – Please Hold the Date.
For registration and further details, please visit and monitor: www.birmingham.ac.uk/ukpsc.
We look forward to seeing you,
Many Thanks and Best Wishes,
UK-PSC (Dr Palak Trivedi and Team)
LONDON LIVER REGENERATIVE MEDICINE NETWORK
Workshop 31st October 2019
This is the second Workshop of the London Liver Regenerative Medicine Network, which is being planned for Thursday 31st October 2019 at the Institute of Hepatology London.
The aim of the Network is to provide a platform for the London Liver Regenerative Medicine research community and facilitate inter/multidisciplinary collaboration across the London Universities and Institutes. The half-day Workshop will highlight the current research in hepatic regenerative medicine and tissue engineering, including cell therapy, organ-on-a-chip, bio-artificial hepatic systems and stem cell biology, to discuss the challenges and future directions for the progression of this field and identify research opportunities for collaborations.
The meeting will include two Keynote Sessions and two Bright Sparks Sessions with shorter talks.
The meeting will be held in the Seminar room of the Institute of Hepatology and will be restricted to 70 persons to facilitate discussion.
For details please contact Dr Luca Urbani on 020-72559843 or e-mail: firstname.lastname@example.org.
Draft programme: Download LLRM workshop - Programme 2019 draft.pdf.
This year the annual meeting of Cholangiocarcinoma-UK will have a basic science theme.
A full programme is planned, featuring a series of invited speakers and talks from abstracts. There will also be a moderated round table discussion on key questions in the basic science of Cholangiocarcinoma and where next. This year will also see the inauguration of the Neil Blenkinsop Memorial Lecture, to be given by Dr Chiara Braconi of the University of Glasgow. Lunch will be provided alongside viewing of posters.
The meeting times are from 9.00am to 5.00pm and a draft programme can be downloaded below.
Venue: Jubilee Conference Centre, Jubliee Campus, University of Nottingham, Nottingham NG8 1BB.
In case of queries, please contact the BASL Secretariat on Samantha@basl.org.uk or +44(0)1543 442154.
Abstracts - may be submitted for either oral or poster presentation at the meeting. They may relate to any aspect of the basic science of Cholangiocarcinoma.
Full guidance on abstract submission can be downloaded > here Download CCA-UK Abstract Process.pdf or viewed via the booking link below.
Abstract deadline: 14 October 2019.
Early Bird Registration - until 14 October 2019.
There are two categories -
- scientists, clinicians, nurses, pharmacists: £50.
- students and medically qualified trainees: £25.
Registration fee from 15 October 2019: £90
Cancellation policy: If you wish to cancel your attendance at this event, please notify the BASL Secretariat by 31 October 2019. Fees are non-refundable. In exceptional circumstances refunds may be made at the sole discretion of BASL.